BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17986101)

  • 1. Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease.
    Rodríguez-Rodríguez E; Sánchez-Juan P; Mateo I; Llorca J; Infante J; García-Gorostiaga I; Berciano J; Combarros O
    Acta Neurol Scand; 2007 Dec; 116(6):409-12. PubMed ID: 17986101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression.
    Caraci F; Bosco P; Signorelli M; Spada RS; Cosentino FI; Toscano G; Bonforte C; Muratore S; Prestianni G; Panerai S; Giambirtone MC; Gulotta E; Romano C; Salluzzo MG; Nicoletti F; Copani A; Drago F; Aguglia E; Ferri R
    Eur Neuropsychopharmacol; 2012 Apr; 22(4):281-9. PubMed ID: 21924590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum VEGF levels are associated with Alzheimer's disease.
    Mateo I; Llorca J; Infante J; Rodríguez-Rodríguez E; Fernández-Viadero C; Peña N; Berciano J; Combarros O
    Acta Neurol Scand; 2007 Jul; 116(1):56-8. PubMed ID: 17587256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease.
    Mocali A; Cedrola S; Della Malva N; Bontempelli M; Mitidieri VA; Bavazzano A; Comolli R; Paoletti F; La Porta CA
    Exp Gerontol; 2004 Oct; 39(10):1555-61. PubMed ID: 15501026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. +10 T/C polymorphisms in the gene of transforming growth factor-beta1 are associated with neurodegeneration and its clinical evolution.
    Arosio B; Bergamaschini L; Galimberti L; La Porta C; Zanetti M; Calabresi C; Scarpini E; Annoni G; Vergani C
    Mech Ageing Dev; 2007 Oct; 128(10):553-7. PubMed ID: 17889927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
    Zhao C; Wang YY; Xiao ZX; Wang YP; Zhang QY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
    Hong GS; Heun R; Jessen F; Popp J; Hentschel F; Kelemen P; Schulz A; Maier W; Kölsch H
    Neurobiol Aging; 2009 May; 30(5):691-6. PubMed ID: 17904251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels.
    Fenoglio C; Galimberti D; Lovati C; Guidi I; Gatti A; Fogliarino S; Tiriticco M; Mariani C; Forloni G; Pettenati C; Baron P; Conti G; Bresolin N; Scarpini E
    Neurobiol Aging; 2004 Oct; 25(9):1169-73. PubMed ID: 15312962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma.
    Wei YS; Xu QQ; Wang CF; Pan Y; Liang F; Long XK
    Tissue Antigens; 2007 Dec; 70(6):464-9. PubMed ID: 17990985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Ser326Cys polymorphism in the DNA repair gene hOGG1 is not associated with sporadic Alzheimer's disease.
    Coppedè F; Mancuso M; Lo Gerfo A; Manca ML; Petrozzi L; Migliore L; Siciliano G; Murri L
    Neurosci Lett; 2007 Mar; 414(3):282-5. PubMed ID: 17240059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between TNF-alpha polymorphisms and Alzheimer's disease in an Italian cohort.
    Tedde A; Putignano AL; Nacmias B; Bagnoli S; Cellini E; Sorbi S
    Neurosci Lett; 2008 Dec; 446(2-3):139-42. PubMed ID: 18834925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association.
    Sjölander A; Minthon L; Bogdanovic N; Wallin A; Zetterberg H; Blennow K
    Neurobiol Aging; 2009 Apr; 30(4):666-8. PubMed ID: 17850927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer's disease.
    Nishimura M; Sakamoto T; Kaji R; Kawakami H
    Neurosci Lett; 2004 Sep; 368(2):140-3. PubMed ID: 15351436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between the TGF-beta1 gene -509C/T polymorphism and tubulointerstitial damage resulting from primary nephrotic syndrome.
    Li Y; Liu FY; Peng YM; Li J; Sun L; Chen X; Duan SB; Ling GH; Guo N; Liu YH
    Ren Fail; 2010 May; 32(4):420-7. PubMed ID: 20446778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
    Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-control study of vascular endothelial growth factor (VEGF) genetic variability in Alzheimer's disease.
    Mateo I; Llorca J; Infante J; Rodríguez-Rodríguez E; Sánchez-Quintana C; Sánchez-Juan P; Berciano J; Combarros O
    Neurosci Lett; 2006 Jun; 401(1-2):171-3. PubMed ID: 16569480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.
    Lee J; Fukumoto H; Orne J; Klucken J; Raju S; Vanderburg CR; Irizarry MC; Hyman BT; Ingelsson M
    Exp Neurol; 2005 Jul; 194(1):91-6. PubMed ID: 15899246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients.
    Rota E; Bellone G; Rocca P; Bergamasco B; Emanuelli G; Ferrero P
    Neurol Sci; 2006 Apr; 27(1):33-9. PubMed ID: 16688597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between Interleukin-18 gene promoter polymorphisms and onset of Alzheimer's disease.
    Segat L; Milanese M; Arosio B; Vergani C; Crovella S
    Neurobiol Aging; 2010 Jan; 31(1):162-4. PubMed ID: 18433937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression.
    Motta M; Imbesi R; Di Rosa M; Stivala F; Malaguarnera L
    Immunol Lett; 2007 Nov; 114(1):46-51. PubMed ID: 17949824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.